Arizest Pharma (India) Private Limited - Company Profile

It is a pharma foreign private limited company based in Bengaluru, Karnataka, India, established in 2015.
2015 Bengaluru, Karnataka, India Active
Last Updated:
Access Report
About Arizest Pharma (India) Private Limited

Arizest Pharma (India) Private Limited, a active foreign private limited company, was established on 11 June 2015 in Bengaluru, Karnataka, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100KA2015FTC080832. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹75.00 Cr and a paid-up capital of ₹66.34 Cr.

It upholds a compliant status. Employing 18 professional, Its leadership includes Manorama Avinash (Director), Chinnasamy Anbarasu (Director), Kuppodi Niranjan (Director). Past directors included Jayadev Shrimanthrao Patil, Lakshmi Jyothsna Naraharisetty, Makkigadde Lakshminarayana Shreepada. It holds ₹40.00 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at No.77D Kiadb Industrial Area, Jigani, Bengaluru, Karnataka, 560100.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100KA2015FTC080832

  • Registration Number

    080832

  • Incorporation Date

    11 June 2015

  • Authorized Capital

    ₹75.00 Cr

  • Paid-Up Capital

    ₹66.34 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 75.00 Cr
  • Paid Up Capital ₹ 66.34 Cr
  • Company Age 10 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 40.00 Cr
  • Revenue Growth **** 0.94%
  • Profit Growth **** -1.29%
  • Ebitda **** -3.18%
  • Net Worth -13.23%
  • Total Assets -4.48%
Company report

Arizest Pharma (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Arizest Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Arizest Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Manorama Avinash Director 11 Jun 2015 Current
Chinnasamy Anbarasu Director 06 May 2024 Current
Kuppodi Niranjan Director 18 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 24 Sep 2020 Past
Pramod Abcsdd Company Secretary 24 Jun 2023 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Arizest Pharma (India).

Arizest Pharma (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.94% increase. The company also saw a slight decrease in profitability, with a 1.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 13.23%.

Arizest Pharma (India) revenue growth over time
Arizest Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.94%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -4.48%
*******
*******
*******
*******
Profit or Loss
*******
 -1.29%
*******
*******
*******
*******
Net Worth
*******
 -13.23%
*******
*******
*******
*******
EBITDA
*******
 -3.18%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Arizest Pharma (India)?

In 2023, Arizest Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹400,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 40.00 Cr
Latest Charge Details
Date Lender Amount Status
16 Dec 2020 Hdfc Bank Limited ₹40.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Arizest Pharma (India)?

Arizest Pharma (India) has a workforce of 18 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Arizest Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arizest Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Arizest Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    Arizest Pharma (India) Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Arizest Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was completed.

  • Director Appointment

    The activity Kuppodi Niranjan was appointed as a Director was appointed as a Director on 18 Mar 2025 & has been associated with this company since 1 year 6 days . was completed.

  • Director Appointment

    The activity Puja Kumari was appointed as a Company Secretary was appointed as a Company Secretary on 04 Sep 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Director Appointment

    Progress on Chinnasamy Anbarasu was appointed as a Director was appointed as a Director on 06 May 2024 & has been associated with this company since 1 year 10 months . was documented.

  • Director Appointment

    Makkigadde Lakshminarayana Shreepada was appointed as a Company Secretary was appointed as a Company Secretary on 29 Jun 2023 & has been associated with this company since 2 years 8 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Arizest Pharma (India) Private Limited?

The CIN of Arizest Pharma (India) Private Limited is U24100KA2015FTC080832.

Where is Arizest Pharma (India) Private Limited headquartered?

Arizest Pharma (India) Private Limited is headquartered at No.77D Kiadb Industrial Area, Jigani, Bengaluru, Karnataka, 560100.

When was Arizest Pharma (India) Private Limited incorporated?

Arizest Pharma (India) Private Limited was incorporated on 11 June 2015.

Who are the current directors of Arizest Pharma (India) Private Limited?

The current directors of Arizest Pharma (India) Private Limited are

What is the primary industry of Arizest Pharma (India) Private Limited?

The primary industry of Arizest Pharma (India) Private Limited is Manufacturing.

Is Arizest Pharma (India) Private Limited a listed company?

Arizest Pharma (India) Private Limited is unlisted.

What is the capital structure of Arizest Pharma (India) Private Limited?

The authorized capital of Arizest Pharma (India) Private Limited is ₹75.00 Cr, and the paid-up capital is ₹66.34 Cr.

What is the compliance status of Arizest Pharma (India) Private Limited?

The compliance status of Arizest Pharma (India) Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available